ANNUAL REPORT FOR YEAR ENDED 8-31-2009

Company

AYTU BIOPHARMA, INC

Filed

October 20, 2009

Period of Report

August 31, 2009

Accession Number

0001079974-09-000776

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →